Related Experiment Video

Updated: Jun 28, 2026

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

The catalytic acid in the dephosphorylation of the Cdk2-pTpY/CycA protein complex by Cdc25B phosphatase

Guilherme Menegon Arantes1

  • 1Departamento de Bioquimica, Instituto de Química, Universidade de São Paulo, São Paulo, SP, Brasil. garantes@iq.usp.br

The Journal of Physical Chemistry. B
|November 5, 2008
PubMed

Insights

Researchers investigated the Cdc25 phosphatase catalytic mechanism to aid anticancer drug design. Molecular dynamics simulations identified the general acid catalyst, crucial for developing targeted Cdc25 inhibitors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Cdc25 phosphatases are key regulators of the cell cycle.
  • Targeting Cdc25 phosphatases is a promising strategy for anticancer therapeutics.
  • The precise catalytic mechanism of Cdc25, particularly the general acid, remains unclear.

Purpose of the Study:

  • To elucidate the catalytic mechanism of Cdc25B.
  • To identify the general acid catalyst in Cdc25B-mediated dephosphorylation.
  • To provide insights for rational inhibitor design against Cdc25 phosphatases.

Main Methods:

  • Utilized molecular dynamics simulations with a calibrated hybrid potential.
  • Simulated the first reaction step of Cdc25B with its natural substrate (Cdk2-pTpY/CycA).
  • Calculated reaction free-energy profiles to analyze the catalytic mechanism.

Main Results:

  • The calculated free-energy profiles closely matched experimental data.
  • The simulations successfully distinguished between proposed general acid identities.
  • Identified key interactions for specific Cdc25 inhibitor design.

Conclusions:

  • The study clarifies the role of the general acid in Cdc25B catalysis.
  • Provides a foundation for developing more effective and specific Cdc25-targeting anticancer drugs.
  • Molecular dynamics simulations are a valuable tool for understanding enzyme mechanisms and guiding drug discovery.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk113:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

Related Concept Videos

Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Separation of Sister Chromatids02:17

Separation of Sister Chromatids

At the transition from prophase to metaphase, there is a reduction in cohesion along the chromosomal arms, resulting in the resolution of sister chromatids. However, residual cohesin connections remain to hold the sister chromatids together until the transition from metaphase to anaphase. The residual connection prevents any premature separation of sister chromatids, blocking the risks of aneuploidy within the daughter cells.
At the onset of anaphase, separase, a proteolytic enzyme, is...